Emerson (EMR) also announced that it is exploring strategic alternatives for its Safety & Productivity segment, including a cash sale, to maximize shareholder value. The segment, which includes Emerson’s legacy tools businesses, contributed $1.4B of sales to Emerson in fiscal year 2024, with 24.5% Adjusted Segment EBITA margins. There is no deadline or definitive timetable set for completion of the strategic alternatives process or assurance that the process will result in any transaction. Emerson does not intend to make further announcements regarding the review of strategic alternatives, beyond the conference call, unless and until the board approves a specific transaction or otherwise determines further disclosure is appropriate or necessary.
Don't Miss Our Christmas Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EMR:
- Emerson Electric Reports Strong Financial Performance in 2024
- Correction: Emerson reports Q4 adjusted EPS $1.48, consensus $1.47
- Emerson reports Q4 adjusted EPS $1.48, consensus $1.47
- Emerson sees FY25 adjusted EPS view to $5.85-$6.05, consensus $5.89
- Emerson reports Q4 adjusted EPS $1.29, consensus $1.47